Recent Presentations: 2008-2011
Statistical Issues in the Assessment of Risk and Benefits of Alternative
Treatment Modalities. Invited talk at: International Symposium on
Business and Industrial Statistics (ISBIS 2012) June 17-21, 2012 Bangkok, Thailand
Meta-analysis in Risk-Benefit Evaluation.
Indian Association for Statistics in Clinical Trials (IASCT) Annual
Conference, April 19-22, 2012,
Good Research Practices for Nonrandomized Studies of Treatment
Effects Using Secondary Data Sources. Invited talk at: 2nd International Symposium on
Biopharmaceutical Statistics, February 28-March 3, 2011, Berlin, Germany.
Reflections on Heterogeneity and Exchangeability in Comparative Effectiveness Research. Invited talk at: 20th Applied Statistics Symposium,
International Chinese Statistical Association (ICSA ), June 26-29, 2011, New York City, NY
Current Issues with Meta-analysis in Medical Research. Instituto
Panamericano de Estudios Avanzados en Probabilidad y Estadistica, PASI,
Semana de Bioinformatica, Bioestadistica, Analisis de Supervivencia, May 3-8, 2010. Guanajuato, Mexico.
Recent Developments in Indirect Treatment Comparisons. Australian Statistical Conference. December 6-9, 2010. Perth, Australia.
A Comparative Study of Entropy-Based Goodness of Fit Tests. Stellenbosch Statistical Symposium: The International Society for Business and
Industrial Statistic. August 24-26, 2009, Stellenbosch, Republic of South Africa
Enhancing the Statistics Profession Globally Through an Educational
Ambassador Initiative. (Panelist with M. Aliaga and F. Scheuren). The 57th Session of
the International Statistical Institute, August 16-22, 2009, Durban, Republic of South Africa
Testing for Normality Based on Entropy. First Annual Symposium of The International Society for Biopharmaceutical Statistics. June 30 - July 2,
2008, Shanghai, China
Drug Safety Assessment. Discussant of Invited Talks at: First Annual Symposium of The International Society for Biopharmaceutical
Statistics. June 30 - July 2, 2008, Shanghai, China